Büşra ARICA, Emrullah BEYAZYILDIZ, Özlem BEYAZYILDIZ

DÜŞÜK DOZ TOPİRAMAT KULLANIMI SONRASI GELİŞEN BİLATERAL AKUT DAR AÇILI GLOKOM VE MİYOPİ

Giriş: Topiramat, epilepsi tedavisinde ve migren profilaksisinde etkili olduğu gösterilen sülfamat sübstitüsyonlu monosakkarid türevi bir ajandır. Bu ilacın kullanımı sırasında özellikle ilk iki hafta içerisinde akut myopi ile birlikte açı kapanması glokomu krizi gelişebilir.

Anahtar Kelimeler:

Glokom, migren, miyopi, topiramat

BILATERAL ACUTE ANGLE CLOSURE GLAUCOMA AND MYOPIA INDUCED BY LOW DOSAGE TOPIRAMATE

day) for prophylaxis of migraine without aura. The patient was found to have significant conjunctival hyperemia, shallow anterior chamber, and bulging iris in both eyes. Grade 1 acute angle was detected in both eyes during gonioscopic examination. There was no pupillary block and intraocular pressure was 40 mmHg in both eyes. Refraction values were measured at -7.00 and -8.00 in the right and left eye, respectively. The patient’s visual acuity was at 0.1 to 0.2. Topiramate treatment was promptly discontinued, topical antiglaucomatous treatment was initiated, and laser peripheral iridotomy was performed on each eye. Intraocular pressure has declined to normal limits, refractive values were zero in both eyes and patient’s visual acuity has restored at follow-up period at 10 days after treatment. Conclusion- Side effects associated with topiramate treatments are known to disappear without long-term damage when the discontinuation of therapy and effective interventions are started early. Therefore, patients and their physicians should be alert for symptoms associated with acute secondary angle closure glaucoma and myopia

Keywords:

Glaucoma, migraine, myopia, topiramate,

PDF

___

Maryanoff BE. Sugarsulfamatesforseizurecontrol: discoveryanddevelopment of topiramate, a structurallyuniqueantiepilepticdrug. CurrentTopics in
MedicinalChemistry. 2009;9(11):1049–1062
JohannessenLandmark C. Antiepilepticdrugs in non-
epilepsydisorders: relationsbetweenmechanisms of
actionandclinicalefficacy. CNS Drugs. 2008;22(1):27–47.
Spaccapelo L, Leschiutta S, Aurea C, Ferrari A.
Topiramate-associatedacuteglaucoma in a
migrainepatientreceivingconcomitantcitalopramtherapy: a case-report.
CasesJournal 2009,2:87
Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-
associatedacute, bilateral, secondaryangle-
closureglaucoma.Ophthalmology. 2004 Jan;111(1):109-11.
Panday VA, RheeDJ.Review of sulfonamide-
inducedacutemyopiaandacutebilateralangle-
closureglaucoma.ComprOphthalmol Update. 2007 Sep-Oct;8(5):271-
-
Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of
topiramate-inducedacute-onsetmyopiaandangleclosureglaucoma.Am J
Ophthalmol. 2004 Jan;137(1):193-5.
Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield
DS. Presumedtopiramateinducedbilateralacuteangleclosureglaucoma.
Am J Ophtalmol.2001;132:112-114
Saffra N, Smith SN, SeidmanCJ.Topiramate-
inducedrefractivechangeandangleclosureglaucomaanditsultrasoundbi
microscopyfindings. BMJ Case Rep. 2012 Aug 1;2012
Medeiros FA, Zhang XY, Bernd AS, Weinreb RN. Angle-
closureglaucomaassociatedwithciliary body detachment in
patientsusingtopiramate. Arch Ophthalmol.2003;121:282-284
Paciuc-Beja M, Retchkiman-Bret M, Velasco-Barona CF,
Galicia-Alfaro VH.
SecondaryBilateralAngleClosureGlaucomaduetoTopiramate.CaseRep
OphthalmolMed. 2011;2011
Sankar PS, Pasquale LR, Grosskreutz CL.
Uvealeffusionandsecondaryangle-
closureglaucomaassociatedwithtopiramateuse. Arch
Ophthalmol.2001;119:1210-1211.
Örüm Ö, Tarakçıoğlu H, Yiğit U. Topiramat kullanımının
tetiklediği miyopik kayma ve bilateralsekonder kapalı açılı glokom.
Turk J Ophthalmol 2012;42:154-6
Willett MC, Edward DP. Refractorytopiramate-
inducedangle-closureglaucoma in a man: a casereport. J Med Case
Reports.2011;26-33
Sbeity Z, Gvozdyuk N, Amde W, Liebmann JM, Ritch R.
Argon laserperipheraliridoplastyfortopiramate-
indusedbilateralacuteangleclosure. J Glaucoma.2009;18:269-71
Lorenzatti M, Nazzarro V, Abdolrahimzadeh S.
Bilateralacuteangleclosureglaucomaandmyopiainducedbytopiramate.C
lin Ter. 2009;160(3):215-6